Sichuan Biokin Pharmaceutical (SHA:688506) enrolled the first subject for the Phase III clinical trial of T-Bren, according to a Shanghai bourse filing on Wednesday.
The drug is being tested in combination with pertuzumab and trastuzumab for the treatment of HER2-positive recurrent or metastatic breast cancer.
Suncorp Group (ASX:SUN) has priced a AU$200 million issue of direct, unsecured, subordinated notes to institutional and wholesale investors, with the margin set at 150 basis points over the three-month bank bill swap rate, according to a Wednesday Australian bourse filing.The company said the notes have an 11-year term with a maturity date of June 1, 2037, with Suncorp holding the option to redeem or resell them on June 1, 2032, or any interest payment date thereafter, subject to Australian Prudential Regulation Authority approval, the filing added.The notes are expected to be issued on or around May 20, with proceeds to fund Tier 2 Capital of one or more regulated entities within the Suncorp Group, and for general funding and capital management purposes, the filing added.The company's shares rose 1% in recent Wednesday trade.
Webjet's (ASX:WJL) Chair Don Clarke is set to retire from the company's board, effective May 20, according to a Wednesday filing with the Australian bourse.The company said Gary Weiss will become interim chair on the same date, per the filing.
Siyaram Recycling Industries (BOM:544047) has secured an order worth 15.1 million Indian rupees from plastics manufacturer Supreme Industries (NSE:SUPREMEIND, BOM:509930), according to a BSE filing on Wednesday.The contract is for the supply of female insert 1/2" CPVC/Aqua threaded toppers within seven days.The company's shares were up over 2% in recent trade.